Clorox up after first-quarter sales, profit beat

By Reuters News

** Shares of Pine-Sol maker Clorox CLX.N up 4.4% at $93.72 in extended trading

** Co beats quarterly sales, profit estimates, helped by resilient demand for its health and wellness products

** Reports Q1 sales of $1.91 billion vs estimates of $1.88 billion - data compiled by LSEG

** Logs quarterly adjusted EPS of $1.55, increased 82% vs estimates of $1.07

** Posts 62% rise in net sales of health and wellness segment for the quarter vs 19% decrease last year

** CLX however maintains FY2027 sales forecast and sees annual adjusted EPS results closer to the low end of the range

** "The cost environment has become more challenging, with higher inflationary pressures reflected in our updated outlook" - co

** As of last close, stock down ~11% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.